Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations (Q33574487)

28 July 2017

1 reference

title

Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations (English)

1 reference

28 July 2017

0 references

0 references

George K Bertsias

1

1 reference

28 July 2017

Dimitrios T Boumpas

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

11 May 2010

1 reference

Nature Reviews Rheumatology

28 July 2017

1 reference

28 July 2017

6

1 reference

28 July 2017

358-367

1 reference

28 July 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2010.62

28 July 2017

0 references

cites work

Epileptic seizures in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Predictors of cognitive dysfunction in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Prospective study of neuropsychiatric events in systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

The ACR classification criteria for headache disorders in SLE fail to classify certain prevalent headache types

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Prevalence of migraine in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Impact of memory impairment on employment status in persons with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Functional outcome after stroke in patients with rheumatoid arthritis and systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Prognostic factors of lupus myelopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: A case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Cognition and immunity; antibody impairs memory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Hippocampal atrophy in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Selective involvement of the amygdala in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurological symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

The management of thrombosis in the antiphospholipid-antibody syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Clinical study and follow-up of 100 patients with the antiphospholipid syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

An investigation in the possible effect of chronic headache on neuropsychological function in aCL-negative patients with SLE.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Cerebral and corpus callosum atrophy in systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Clinical description of seizures in patients with systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Stroke subtypes among young patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Distinct subtypes of myelitis in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Skin denervation and cutaneous vasculitis in systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Peripheral neuropathy in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Peripheral neuropathy in systemic lupus erythematosus--a longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2010.62

Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies

31 March 2020

1 reference

12 December 2020

Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data

1 reference

12 December 2020

Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study

1 reference

12 December 2020

Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus.

1 reference

12 December 2020

Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus.

1 reference

12 December 2020

Somatic and psychological features of headache in systemic lupus erythematosus.

1 reference

12 December 2020

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

1 reference

12 December 2020

Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus

1 reference

12 December 2020

Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus.

1 reference

12 December 2020

The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus.

1 reference

12 December 2020

High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and health-related quality of life

1 reference

12 December 2020

Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2010.62

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference